The U.S. Food and Drug Administration on Friday approved a treatment for Alzheimer’s disease, the second of a new category of medications. Given the high prevalence of dementia within nursing homes, any new treatments for Alzheimer’s or similar conditions would shape care and services that providers deliver. Nearly 50% of nursing home residents have a […]
Leqembi
Subscribe
Receive industry updates and breaking news from SNN.